Cargando…

First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia

BACKGROUND: Placental growth factor (PGF), soluble fms-like tyrosine kinase 1 (sFLT1) and asymmetric dimethylarginine (ADMA) are involved in the pathogenesis of preeclampsia. Abnormal maternal sFLT1, PGF and ADMA levels are detectable weeks before the onset of preeclampsia. OBJECTIVE: To investigate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bian, Zheng, Shixia, Chenzi, Duan, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408038/ https://www.ncbi.nlm.nih.gov/pubmed/25906026 http://dx.doi.org/10.1371/journal.pone.0124684

Ejemplares similares

First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia
por: Saxena, Aditi R, et al.
Publicado: (2013)

A simple detection method for the serum sFLT1 protein in preeclampsia
por: Shibuya, Masabumi, et al.
Publicado: (2021)

RNAi Modulation of Placental sFLT1 for the Treatment of Preeclampsia.
por: Turanov, Anton A., et al.
Publicado: (2018)

Circulating Levels of sFlt1 Splice Variants as Predictive Markers for the Development of Preeclampsia
por: Souders, Colby A., et al.
Publicado: (2015)

Trophoblast-Targeted Nanomedicine Modulates Placental sFLT1 for Preeclampsia Treatment
por: Li, Lei, et al.
Publicado: (2020)

Efficiency of sFlt-1/PlGF Ratio in Preeclampsia Diagnosis
por: Tataru-Copos, Anca-Florina, et al.
Publicado: (2022)

Predicting Preeclampsia Pregnancy Termination Time Using sFlt-1
por: Tanaka, Hiroaki, et al.
Publicado: (2022)

Influential Serum Kinases (Non-sFlt-1) and Phosphatases in Preeclampsia—Systematic Review and Metanalysis
por: Marrufo-Gallegos, Karla Cecilia, et al.
Publicado: (2023)

Maternal Serum Angiogenic Factor sFlt-1 to PlGF Ratio in Preeclampsia: A Useful Marker for Differential Diagnosis and Prognosis Evaluation in Chinese Women
por: Lou, Wei-zhen, et al.
Publicado: (2019)

sFlt-1, Not PlGF, Is Related to Twin Gestation Choronicity in the First and Third Trimesters of Pregnancy
por: Kozłowski, Szymon, et al.
Publicado: (2021)

Correlation of sFlt/PlGF ratio with severity of preeclampsia in an Indian population
por: Kumar, Namrata, et al.
Publicado: (2023)

MIF Increases sFLT1 Expression in Early Uncomplicated Pregnancy and Preeclampsia
por: Yong, Qing, et al.
Publicado: (2023)

Diagnostic accuracy of sFlt1/PlGF ratio as a marker for preeclampsia
por: Nikuei, Pooneh, et al.
Publicado: (2020)

The sFlt-1/PlGF Ratio Trend Is Useful in Predicting Preeclampsia Severity in Hyperreactio Luteinalis Complicated with Preeclampsia
por: Miyatake, Risa, et al.
Publicado: (2023)

Increased sFlt-1 to PlGF Ratio in Women Who Subsequently Develop Preeclampsia
por: Kim, Shin-Young, et al.
Publicado: (2007)

Abnormal expression and clinical significance of 25-hydroxyvitamin D and sFlt-1 in patients with preeclampsia
por: Chen, Xinhua, et al.
Publicado: (2019)

Enhanced Serum Levels of sFlt1: Impact on Materno–Fetal CMV Transmission
por: Penka, Lukas, et al.
Publicado: (2020)

Evaluation of first trimester maternal serum inhibin-A for preeclampsia screening
por: Moungmaithong, Sakita, et al.
Publicado: (2023)

Elevation of maternal serum sFlt-1 in pregnancy with mirror syndrome caused by fetal cardiac failure
por: Katoh, Yoshihisa, et al.
Publicado: (2018)

VEGF and sFLT-1 in serum of PIH patients and effects on the foetus
por: Tang, Yanhong, et al.
Publicado: (2019)

Full-Length Human Placental sFlt-1-e15a Isoform Induces Distinct Maternal Phenotypes of Preeclampsia in Mice
por: Szalai, Gabor, et al.
Publicado: (2015)

Carbon Monoxide Prevents Hypertension and Proteinuria in an Adenovirus sFlt-1 Preeclampsia-Like Mouse Model
por: Venditti, Carolina C., et al.
Publicado: (2014)

Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany
por: Schlembach, Dietmar, et al.
Publicado: (2018)

Influence of the sFlt-1/PlGF Ratio on Clinical Decision-Making in Women with Suspected Preeclampsia
por: Klein, Evelyn, et al.
Publicado: (2016)

Nested Case–Control Study of Corin Combined with sFlt-1/PLGF in Predicting the Risk of Preeclampsia
por: Liu, Mei, et al.
Publicado: (2021)

Association of sFlt-1 and C-reactive protein with outcomes in severe preeclampsia: A cohort study
por: Nóbrega, Leandro, et al.
Publicado: (2022)

Predictive value of the sFlt-1/PlGF ratio in women with suspected preeclampsia: An update (Review)
por: Velegrakis, Alexandros, et al.
Publicado: (2023)

Systemic Maternal Human sFLT1 Overexpression Leads to an Impaired Foetal Brain Development of Growth-Restricted Foetuses upon Experimental Preeclampsia
por: Vogtmann, Rebekka, et al.
Publicado: (2022)

Correlation of Maternal Serum Homocysteine in the First Trimester with the Development of Gestational Hypertension and Preeclampsia
por: Sun, Feng, et al.
Publicado: (2017)

Clinical value of serum VEGF and sFlt-1 in pernicious placenta previa
por: Wang, Na, et al.
Publicado: (2021)

Increased LIGHT leading to sFlt-1 elevation underlies the pathogenic link between hydatidiform mole and preeclampsia
por: Iriyama, Takayuki, et al.
Publicado: (2019)

Oxidative and Inflammatory Imbalance in Placenta and Kidney of sFlt1-Induced Early-Onset Preeclampsia Rat Model
por: Santana-Garrido, Álvaro, et al.
Publicado: (2022)

Placental and maternal sFlt1/PlGF expression in gestational diabetes mellitus
por: Nuzzo, Anna Maria, et al.
Publicado: (2021)

Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy
por: Gurnadi, Jeffry Iman, et al.
Publicado: (2015)

Assessment of the SFlt-1 and sFlt-1/25(OH)D Ratio as a Diagnostic Tool in Gestational Hypertension (GH), Preeclampsia (PE), and Gestational Diabetes Mellitus (GDM)
por: Walentowicz-Sadlecka, Malgorzata, et al.
Publicado: (2019)

Micro- and Nano-vesicles from First Trimester Human Placentae Carry Flt-1 and Levels Are Increased in Severe Preeclampsia
por: Tong, Mancy, et al.
Publicado: (2017)

Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction – implications for treating preeclampsia
por: Kaitu’u-Lino, Tu’uhevaha J., et al.
Publicado: (2018)

Deletion of GIT1 Impacts eNOS Activity To Aggravate sFlt-1–Induced Preeclampsia Phenotype in Mice
por: Zhang, Shenghong, et al.
Publicado: (2018)

A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia
por: Pant, Vivek, et al.
Publicado: (2019)

Relationship between the sFlt-1/PlGF ratio and the optical coherence tomographic features of chorioretina in patients with preeclampsia
por: Lee, Jaekyoung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7ec58akc1v9sf2n7sua693tjb5